INTERNATIONAL PATENT: HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD. FILES APPLICATION FOR "PEPTIDE MODULATORS OF NEUROLIGIN 4-NEUREXIN 1-BETA AXIS FOR TREATMENT OF CONDITIONS THAT INVOLVE ABNORMAL INFLAMMATORY RESPONSE"

GENEVA, March 24 -- HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD. (Jerusalem BioParkHadassah Ein Kerem Medical CenterP.O.B. 120009112001 Jerusalem) filed a patent application (PCT/IL2024/050910) for "PEPTIDE MODULATORS OF NEUROLIGIN 4-NEUREXIN 1-BETA AXIS FOR TREATMENT OF CONDITIONS THAT INVOLVE ABNORMAL INFLAMMATORY RESPONSE" on Sep 11, 2024. With publication no. WO/2025/057155, the details related to the patent application was published on Mar 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SAFADI, Rifaat (Jerusalem BioParkHadassah Ein Kerem Medical CenterP.O.B. 120009112001 J...